Abstract
To the Editor; A Commentary on "Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden".
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have